158 related articles for article (PubMed ID: 29285684)
1. Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness.
Caroff SN; Leong SH; Ng-Mak D; Campbell EC; Berkowitz RM; Rajagopalan K; Chuang CC; Loebel A
Community Ment Health J; 2018 Aug; 54(6):725-734. PubMed ID: 29285684
[TBL] [Abstract][Full Text] [Related]
2. Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration.
Shi L; Ascher-Svanum H; Chiang YJ; Zhao Y; Fonseca V; Winstead D
BMC Psychiatry; 2009 Dec; 9():80. PubMed ID: 20021664
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in antipsychotics prescribed to veterans with serious mental illness.
Schwartz E; Charlotte M; Slade E; Medoff D; Li L; Dixon L; Kilbourne A; Kreyenbuhl J
Gen Hosp Psychiatry; 2015; 37(4):347-51. PubMed ID: 25936673
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in mood stabilizer medications prescribed to Veterans with serious mental illness.
Charlotte M; Schwartz E; Slade E; Medoff D; Li L; Dixon L; Kilbourne AM; Kreyenbuhl J
J Affect Disord; 2015 Dec; 188():112-7. PubMed ID: 26361066
[TBL] [Abstract][Full Text] [Related]
5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
6. Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness.
Khatana SA; Kane J; Taveira TH; Bauer MS; Wu WC
PLoS One; 2011 Apr; 6(4):e19298. PubMed ID: 21541294
[TBL] [Abstract][Full Text] [Related]
7. Ethnicity and diagnostic patterns in veterans with psychoses.
Blow FC; Zeber JE; McCarthy JF; Valenstein M; Gillon L; Bingham CR
Soc Psychiatry Psychiatr Epidemiol; 2004 Oct; 39(10):841-51. PubMed ID: 15669666
[TBL] [Abstract][Full Text] [Related]
8. Oral health in Veterans Affairs patients diagnosed with serious mental illness.
Kilbourne AM; Horvitz-Lennon M; Post EP; McCarthy JF; Cruz M; Welsh D; Blow FC
J Public Health Dent; 2007; 67(1):42-8. PubMed ID: 17436978
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the metabolic syndrome in veterans with schizophrenia.
Meyer J; Loh C; Leckband SG; Boyd JA; Wirshing WC; Pierre JM; Wirshing D
J Psychiatr Pract; 2006 Jan; 12(1):5-10. PubMed ID: 16432440
[TBL] [Abstract][Full Text] [Related]
10. Racial/Ethnic disparities in monitoring metabolic parameters for patients with schizophrenia receiving antipsychotic medications.
Phillips KL; Copeland LA; Zeber JE; Stock EM; Tsan JY; MacCarthy AA
Am J Geriatr Psychiatry; 2015 Jun; 23(6):596-606. PubMed ID: 25154537
[TBL] [Abstract][Full Text] [Related]
11. Racial disparity in the use of atypical antipsychotic medications among veterans.
Copeland LA; Zeber JE; Valenstein M; Blow FC
Am J Psychiatry; 2003 Oct; 160(10):1817-22. PubMed ID: 14514496
[TBL] [Abstract][Full Text] [Related]
12. Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.
Hsu C; Ried LD; Bengtson MA; Garman PM; McConkey JR; Rahnavard F
J Am Pharm Assoc (2003); 2008; 48(3):393-400. PubMed ID: 18595825
[TBL] [Abstract][Full Text] [Related]
13. Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.
Kreyenbuhl JA; Valenstein M; McCarthy JF; Ganoczy D; Blow FC
Psychiatr Serv; 2007 Apr; 58(4):489-95. PubMed ID: 17412850
[TBL] [Abstract][Full Text] [Related]
14. What happened to lithium? Antidepressant augmentation in clinical settings.
Valenstein M; McCarthy JF; Austin KL; Greden JF; Young EA; Blow FC
Am J Psychiatry; 2006 Jul; 163(7):1219-25. PubMed ID: 16816227
[TBL] [Abstract][Full Text] [Related]
15. Complexity of patients with mental healthcare needs cared for by mental health clinical pharmacist practitioners in Veterans Affairs.
Jasuja GK; Reisman JI; Miller DR; Ansara ED; Chiulli DL; Moore T; Ourth HL; Tran MH; Smith EG; Morreale AP; McCullough MM
Am J Health Syst Pharm; 2024 May; 81(11):e289-e295. PubMed ID: 38468398
[TBL] [Abstract][Full Text] [Related]
16. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder.
Nayerifard R; Bureng MA; Zahiroddin A; Namjoo M; Rajezi S
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S411-S416. PubMed ID: 28927969
[TBL] [Abstract][Full Text] [Related]
17. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
Mohamed S; Leslie DL; Rosenheck RA
J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
[TBL] [Abstract][Full Text] [Related]
18. Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
Caroff SN; Leong SH; Roberts CB; Berkowitz RM; Campbell EC
J Clin Psychopharmacol; 2020; 40(4):373-380. PubMed ID: 32639290
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome among Australians with severe mental illness.
John AP; Koloth R; Dragovic M; Lim SC
Med J Aust; 2009 Feb; 190(4):176-9. PubMed ID: 19220180
[TBL] [Abstract][Full Text] [Related]
20. Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia.
Dassori AM; Copeland LA; Zeber JE; Miller AL
Psychiatr Serv; 2011 Jan; 62(1):47-53. PubMed ID: 21209299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
